CareDx to Present at UNOS Transplant Management Forum
CareDx, Inc. (Nasdaq: CDNA) will exhibit at the 29th Annual UNOS Transplant Management Forum from April 19-22, 2021.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
CareDx, Inc. (Nasdaq: CDNA) will exhibit at the 29th Annual UNOS Transplant Management Forum from April 19-22, 2021. On April 20, 2021, at 11:00 a.m. EDT, they will host a symposium titled “Providing Personalized Care for Every Step on the Transplant Journey.” Key topics include pre-transplant care with TX Connect, quality care with XynQAPI, and post-transplant care with AlloSure® dd-cfDNA. CareDx aims to provide integrated digital solutions to improve transplant patient care, highlighted by the recent acquisition of TX Connect.
Details
News Market Reaction – CDNA
The recorded move for CDNA in the trading session of this news was -3.77%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Company to showcase its latest integrated solutions for improving care across the whole transplant journey
SOUTH SAN FRANCISCO, Calif., April 16, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced it will be exhibiting at the 29th Annual UNOS Transplant Management Forum (TMF), which takes place virtually between April 19-22, 2021.
On April 20, 2021 at 11:00 a.m. EDT, CareDx will be hosting a symposium titled “Providing Personalized Care for Every Step on the Transplant Journey,” which will include the following topics:
- The Transplant Patient
- Pre-transplant Care with TX Connect and XynCare
- Quality Care with XynQAPI
- Post-transplant Care with AlloSure® dd-cfDNA
“CareDx is thrilled to join TMF this year and share its comprehensive suite of integrated digital solutions that provide better tools for those who care for transplant patients,” said Kashif Rathore, Senior Vice President, Digital Business, CareDx. “With the recent inclusion of TX Connect into the CareDx family, we now offer solutions at every critical step of the transplant patient journey—from transplant referral to post transplant care.”
About CareDx
CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit: www.CareDx.com.
CONTACTS:
CareDx, Inc.
Sasha King
Chief Marketing Officer
415-287-2393
sking@caredx.com
Investor Relations
Greg Chodaczek
347-610-7010
investor@caredx.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.